DE3783073D1 - Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen. - Google Patents

Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen.

Info

Publication number
DE3783073D1
DE3783073D1 DE8787303507T DE3783073T DE3783073D1 DE 3783073 D1 DE3783073 D1 DE 3783073D1 DE 8787303507 T DE8787303507 T DE 8787303507T DE 3783073 T DE3783073 T DE 3783073T DE 3783073 D1 DE3783073 D1 DE 3783073D1
Authority
DE
Germany
Prior art keywords
microorganisms
complex
animal cells
modified cellulose
cellulose gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787303507T
Other languages
English (en)
Other versions
DE3783073T2 (de
Inventor
Shigeru C O Central R Yamanaka
Yuzuru C O Central Researc Eto
Satoshi C O Central Res Takano
Kunihiko C O Central Watanabe
Hiroshiro C O Central R Shibai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of DE3783073D1 publication Critical patent/DE3783073D1/de
Application granted granted Critical
Publication of DE3783073T2 publication Critical patent/DE3783073T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/14Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
    • C08B11/145Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups with basic nitrogen, e.g. aminoalkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02Cellulose; Modified cellulose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/78Cellulose
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/948Microorganisms using viruses or cell lines
DE8787303507T 1986-04-22 1987-04-22 Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen. Expired - Lifetime DE3783073T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9247986 1986-04-22
JP16955486 1986-07-18

Publications (2)

Publication Number Publication Date
DE3783073D1 true DE3783073D1 (de) 1993-01-28
DE3783073T2 DE3783073T2 (de) 1993-04-29

Family

ID=26433903

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787303507T Expired - Lifetime DE3783073T2 (de) 1986-04-22 1987-04-22 Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen.

Country Status (3)

Country Link
US (1) US5558861A (de)
EP (1) EP0243151B1 (de)
DE (1) DE3783073T2 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079162A (en) * 1986-08-28 1992-01-07 Weyerhaeuser Company Reticulated cellulose and methods and microorganisms for the production thereof
US5821109A (en) * 1985-10-18 1998-10-13 Monsanto Life Sciences Co. Reticulated cellulose and methods and microorganisms for the production thereof
US4863565A (en) * 1985-10-18 1989-09-05 Weyerhaeuser Company Sheeted products formed from reticulated microbial cellulose
US5871978A (en) * 1985-10-18 1999-02-16 Monsanto Life Sciences Co Method of producing reticulated cellulose having type II crystalline cellulose
US5144021A (en) * 1985-10-18 1992-09-01 Weyerhaeuser Company Reticulated cellulose and methods and microorganisms for the production thereof
DE3883252T2 (de) * 1987-12-18 1993-11-25 Immunex Corp Örtliche wundheilmittel, die interleukin-1-proteine enthalten.
US5207826A (en) * 1990-04-20 1993-05-04 Weyerhaeuser Company Bacterial cellulose binding agent
FR2661414B1 (fr) * 1990-04-25 1995-03-24 Michel Jean Pierre Produit a base de keratines modifiees, son procede de preparation et les applications notamment en medecine humaine ou veterinaire.
DE69523443T2 (de) * 1994-02-18 2002-06-27 Kanebo Ltd Material zur wundbedeckung
FI111011B (fi) 1997-01-15 2003-05-15 Orion Yhtymae Oyj Mikro-organismien kiinteä kasvualusta, sen valmistus ja käyttö
US6123731A (en) * 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture
US5962053A (en) * 1998-02-17 1999-10-05 Viskase Corporation Edible film and method
US20030228288A1 (en) 1999-10-15 2003-12-11 Scarborough Nelson L. Volume maintaining osteoinductive/osteoconductive compositions
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US7323193B2 (en) 2001-12-14 2008-01-29 Osteotech, Inc. Method of making demineralized bone particles
US6764988B2 (en) 2001-04-18 2004-07-20 Kimberly-Clark Worldwide, Inc. Skin cleansing composition incorporating anionic particles
US7544670B2 (en) 2001-06-14 2009-06-09 The Regents Of The University Of California HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing
WO2002102982A2 (en) * 2001-06-14 2002-12-27 Regents Of The University Of California Hoxd3 compositions ad methods for improved wound healing
US7163691B2 (en) 2001-10-12 2007-01-16 Osteotech, Inc. Bone graft
US20040142019A1 (en) * 2003-01-16 2004-07-22 Xylos Corporation Microbial-derived cellulose amorphous hydrogel wound dressing
WO2004064880A1 (en) * 2003-01-16 2004-08-05 Xylos Corporation Microbial-derived cellulose amorphous hydrogel wound dressing
DE60302326T2 (de) * 2003-01-16 2006-07-27 Xylos Corp. Wundauflage mit amorphem Hydrogel auf Basis mikrobiell veränderter Cellulose
WO2004110513A1 (ja) * 2003-06-10 2004-12-23 Hokkaido Technology Licensing Office Co., Ltd. 生体適合性を有する超高強度ゲル
WO2004110308A2 (en) 2003-06-11 2004-12-23 Osteotech, Inc. Osteoimplants and methods for their manufacture
US20050037082A1 (en) * 2003-08-13 2005-02-17 Wan-Kei Wan Poly(vinyl alcohol)-bacterial cellulose nanocomposite
US9206414B2 (en) * 2003-08-13 2015-12-08 Axcelon Biopolymers Corporation Anisotropic nanocomposite hydrogel
US8465771B2 (en) * 2005-03-30 2013-06-18 The University Of Western Ontario Anisotropic hydrogels
WO2006113796A2 (en) * 2005-04-20 2006-10-26 Xylos Corporation Microbial cellulose materials for use in transdermal drug delivery system
WO2007056671A1 (en) 2005-11-02 2007-05-18 Osteotech, Inc. Hemostatic bone graft
US20070128243A1 (en) 2005-12-02 2007-06-07 Xylos Corporation Implantable microbial cellulose materials for various medical applications
US7709631B2 (en) 2006-03-13 2010-05-04 Xylos Corporation Oxidized microbial cellulose and use thereof
US20070286884A1 (en) * 2006-06-13 2007-12-13 Xylos Corporation Implantable microbial cellulose materials for hard tissue repair and regeneration
ITTO20060932A1 (it) * 2006-12-29 2008-06-30 Medestea Res & Production S P A Procedimento per la produzione di una pellicola a base di cellulosa, da utilizzare per la copertura, riparazione, rigenerazione e cicatrizzazione di lesioni cutanee e tissutali e pellicola cosi' ottenuta.
EP2070557A1 (de) 2007-12-12 2009-06-17 Xylos Corporation Implantierbare mikrobielle Zellulosematerialien zur Hartgewebereparatur und -wiederherstellung
AU2009308191A1 (en) 2008-10-24 2010-04-29 Warsaw Orthopedic, Inc. Compositions and methods for promoting bone formation
US20100159046A1 (en) * 2008-12-19 2010-06-24 Xylos Corporation Minimal tissue attachment implantable materials
KR101200392B1 (ko) * 2010-07-12 2012-11-13 주식회사 바이오피드 혈액 단백질 삼출을 동반하는 피부질환들의 치료 및 증상완화용 패치
FI123988B (fi) 2010-10-27 2014-01-31 Upm Kymmene Corp Soluviljelymateriaali
FI123694B (en) 2011-12-22 2013-09-30 Upm Kymmene Corp Matrix and composition for microbial culture of gram-positive bacteria
FI125965B (en) 2012-09-25 2016-04-29 Upm Kymmene Corp Three-dimensional cell culture
FI126109B (en) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibril polysaccharide for use in the control and prevention of constriction and scarring
AU2014366222B2 (en) 2013-12-16 2018-07-19 Nutrition & Biosciences USA 4, Inc. Use of poly alpha-1,3-glucan ethers as viscosity modifiers
US9957334B2 (en) 2013-12-18 2018-05-01 E I Du Pont De Nemours And Company Cationic poly alpha-1,3-glucan ethers
EP3158043B1 (de) 2014-06-19 2021-03-10 Nutrition & Biosciences USA 4, Inc. Zusammensetzungen mit einer oder mehreren poly-alpha-1,3-glucan-ether-verbindungen
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
US20190307904A1 (en) 2016-03-30 2019-10-10 Convatec Technologies Inc. Modified wound dressings
CN110997018A (zh) * 2017-08-01 2020-04-10 医疗发明株式会社 止血材料及含有其的创伤敷料
CN112138215B (zh) * 2020-09-26 2021-11-05 江苏大学 基于纳米纤维素的细胞生长因子缓释各向异性支架构建方法和应用
CN113308937A (zh) * 2021-05-28 2021-08-27 陕西科技大学 一种细胞培养纸及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464468A (en) * 1968-03-29 1984-08-07 Agence Nationale De Valorisation De La Recherche (Anvar) Immobilization of active protein by cross-linking to inactive protein
US4036693A (en) * 1976-02-02 1977-07-19 Massachusetts Institute Of Technology Treatment of cell culture microcarries
DE2967509D1 (en) * 1978-12-26 1985-10-10 Massachusetts Inst Technology Skin-equivalent
SE445116B (sv) * 1979-09-12 1986-06-02 Pharmacia Fine Chemicals Ab Sett att odla celler pa mikroberare med fibronektinytskikt
JPS6125481A (ja) * 1984-07-12 1986-02-04 Noguchi Kenkyusho 固定依存性細胞培養用ビ−ズ担体
BR8404937A (pt) * 1984-10-01 1986-05-06 Bio Fill Ind E Comercio De Pro Processo para preparacao de pelicula de celulose,pelicula de celulose obtida pelo mesmo,implante de pele artificial,processo de tratamento de lesoes empregando a referida pelicula de celulose e utilizacao

Also Published As

Publication number Publication date
DE3783073T2 (de) 1993-04-29
EP0243151A3 (en) 1988-08-31
US5558861A (en) 1996-09-24
EP0243151B1 (de) 1992-12-16
EP0243151A2 (de) 1987-10-28

Similar Documents

Publication Publication Date Title
DE3783073D1 (de) Modifiziertes, durch mikroorganismen hergestelltes zellulose-gel und sein komplex mit tierischen zellen.
DE3767560D1 (de) Makrolide verbindungen, ihre herstellung und verwendung.
DE3780396D1 (de) Benzoylharnstoff-derivate, deren herstellungsverfahren und diese enthaltendes pestizides mittel.
DE3768598D1 (de) Neue retinoide, deren herstellung und verwendung als pharmazeutika.
DE3579435D1 (de) Polymerisationskatalysator, seine herstellung und seine anwendung.
DE3480794D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3481114D1 (de) Gekreuzte polymerlaminate, deren herstellung und vorrichtungen dazu.
DE3668326D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3785493D1 (de) Gekraeuselte, zellige faser mit in den falten zusammengefallenen zellen.
DE3584410D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3577719D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3677115D1 (de) Zusammengesetzter ionenaustauscher und seine herstellung.
DE3689753D1 (de) Landwirtschaftchemikalien erzeugende endosymbiotische mikroorganismen und deren herstellung und verwendung.
DE3784479D1 (de) Diagnostisches hilfsmittel, seine herstellung und seine verwendung.
DE3575148D1 (de) Polymerisationskatalysator, seine herstellung und seine anwendung.
DE3682491D1 (de) Immobilisierter c-peptid-antikoerper, seine herstellung und verwendung.
DE3889980D1 (de) Reaktivfarbstoffe, deren Herstellung und Verwendung.
DE3484531D1 (de) Tetrahydrobenzotriazole, deren herstellung und verwendung.
DE3751270T2 (de) Alkali-resistente Cellulasen und Mikroorganismen, fähig zu ihrer Herstellung.
DE3670087D1 (de) Absorbierende polymere, deren herstellung und verwendung.
ATE77371T1 (de) 3-carbonyl-1-aminoalkyl-1h-indole, verwendbar als analgetika und ihre herstellung.
DE3381105D1 (de) Aktivierung biovertraeglicher terpolymere mit biologischen stoffen, deren anzubindende komplemente pathologische effektoren sind.
DE68903435D1 (de) Aminoketale, deren herstellung und deren verwendung als fungizides mittel.
DE3789352T2 (de) Neue biphenylabkömmlinge, deren herstellung und verwendung.
DE3773822D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition